Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial

• Aurélien Lambert ,

  Contributed equally to this work with: Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, Thierry Conroy

  Roles Formal analysis, Project administration, Validation, Writing – original draft, Writing – review & editing

  * E-mail: a.lambert@nancy.unicancer.fr

  Affiliation Department of medical oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France

  http://orcid.org/0000-0001-9990-1201

  ⨯
• Marta Jarlier ,

  Contributed equally to this work with: Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, Thierry Conroy

  Roles Data curation, Formal analysis, Methodology, Writing – review & editing

  Affiliation Biostatistics unit, Institut régional du cancer de Montpellier, Parc Euromédecine, Montpellier, France

  ⨯
• Sophie Gourgou Bourgade ,

  Contributed equally to this work with: Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, Thierry Conroy

  Roles Data curation, Formal analysis, Methodology, Writing – review & editing

  Affiliation Biostatistics unit, Institut régional du cancer de Montpellier, Parc Euromédecine, Montpellier, France

  ⨯
• Thierry Conroy

  Contributed equally to this work with: Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, Thierry Conroy

  Roles Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Writing – review & editing

  Affiliation Department of medical oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France

  ⨯